WHO ICTRP trial
A 52-week, multicenter study to assess the time course of response to…
NL-OMON47596 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON47596 |
|---|---|
| Public title | A 52-week, multicenter study to assess the time course of response to secukinumab on joint inflammation using Power Doppler ultrasonography in patients with active psoriatic arthritis |
| Scientific title | A 52-week, multicenter study to assess the time course of response to secukinumab on joint inflammation using Power Doppler ultrasonography in patients with active psoriatic arthritis - Ultimate study |
| Primary sponsor | Novartis |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational invasive |
| Phase | 3 |
| Countries | The Netherlands |
| Conditions | gewrichtsaandoeningen, reumatische aandoeningen active psoriatic arthritis;10040792;active psoriatic arthritis |
| Interventions | ;active psoriatic arthritis;joint inflammation;Power Doppler ultrasonography;secukinumab |
| Registration date | Jul 3, 2019 |
| Target size | 10 |
| Secondary IDs | 2015 002394 38;NCT02662985;NL58012.029.16 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: